Financial results - B & S PHARM SRL

Financial Summary - B & S Pharm Srl
Unique identification code: 18090189
Registration number: J26/1893/2005
Nace: 4773
Sales - Ron
104.628
Net Profit - Ron
320
Employee
1
The most important financial indicators for the company B & S Pharm Srl - Unique Identification Number 18090189: sales in 2023 was 104.628 euro, registering a net profit of 320 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - B & S Pharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 147.392 141.390 141.147 152.422 17.510 0 0 0 0 104.628
Total Income - EUR 147.394 141.392 141.150 152.425 17.687 89 0 0 0 104.628
Total Expenses - EUR 126.324 134.280 132.468 143.534 22.548 1.970 3.165 3.050 18.795 104.219
Gross Profit/Loss - EUR 21.071 7.112 8.682 8.891 -4.861 -1.881 -3.165 -3.049 -18.795 410
Net Profit/Loss - EUR 17.909 5.277 7.148 7.321 -5.038 -1.884 -3.165 -3.049 -18.795 320
Employees 2 3 3 2 1 1 0 0 0 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.

Check the financial reports for the company - B & S Pharm Srl

Rating financiar

Financial Rating -
B & S Pharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
B & S Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
B & S Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
B & S Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - B & S Pharm Srl - CUI 18090189

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 1.209 3.136 3.649 1.961 503 409 160 0 0 0
Current Assets 84.609 72.608 65.692 72.135 24.172 25.040 25.711 25.104 10.949 75.200
Inventories 32.463 20.463 23.151 21.084 15.774 15.469 15.184 14.847 2 1.915
Receivables 30.034 21.112 12.610 30.045 6.099 8.728 9.630 10.145 10.819 68.875
Cash 22.112 31.032 29.930 21.006 2.299 843 898 111 128 4.410
Shareholders Funds 29.387 27.710 12.308 12.898 7.623 5.591 2.320 -781 -19.578 -19.198
Social Capital 45 45 45 88 86 84 83 81 81 81
Debts 56.431 48.034 57.044 61.210 17.053 19.857 23.552 25.884 30.526 94.449
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 75.200 euro in 2023 which includes Inventories of 1.915 euro, Receivables of 68.875 euro and cash availability of 4.410 euro.
The company's Equity was valued at -19.198 euro, while total Liabilities amounted to 94.449 euro. Equity increased by 320 euro, from -19.578 euro in 2022, to -19.198 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - B & S Pharm Srl

Comments - B & S Pharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.